Table 2.
Multivariate analysis results for baseline plaque Vp as the outcome variable.
| Model 1 |
Model 2 |
|||||
|---|---|---|---|---|---|---|
| Variable | β | (95% CI) | P Value | β | (95% CI) | P Value |
| Duration of statin therapy | 0.056* | 0.004* | ||||
| 1-5 years vs. <1 year | −0.0189 | (−0.045, 0.007) | −0.0238 | (−0.048, 0.000) | ||
| >5 years vs. <1 year | −0.0282 | (−0.057, 0.000) | −0.0365 | (−0.061, −0.012) | ||
|
| ||||||
| Log(lipoprotein(a)), per 1 SD increase | 0.0091 | (0.000, 0.018) | 0.049 | 0.0096 | (0.001, 0.019) | 0.040 |
|
| ||||||
| Age, per 10 year increase | −0.0024 | (−0.014, 0.009) | 0.69 | - | ||
|
| ||||||
| Body mass index, per 1 SD increase | 0.0014 | (−0.001, 0.004) | 0.25 | - | ||
|
| ||||||
| Presence of metabolic syndrome | 0.0149 | (−0.010, 0.040) | 0.25 | - | ||
Model 1: initial model containing all variables significantly associated with Vp in univariate analysis;
Model 2: final model after applying backwards elimination to model 1;
β: regression coefficient;
*
Trend test.